SoftBank Group Corp. has led a $1.1 billion equity investment in Switzerland-based healthcare startup Roivant Sciences.

The investment will be made through the Vision Fund, which according to London's Financial Times, is the fund's first backing of a drugmaker and the largest private financing in the healthcare industry.

The investment is the latest in the string of bets recently made by SoftBank.